[ad_1]
Sources in the newspaper immediately assured that there were no problems with the doses of Johnson & Johnson vaccine that had already been delivered to the distribution and vaccination points, since the latter were made in the Netherlands.
However, 15 million. The doses, which were to be ready for use in April, were manufactured at Emergent Biosolutions’ plant in Baltimore.
Johnson & Johnson soon admitted to finding problems with the vaccine dose components, and The New York Times had previously reported that workers accidentally mixed ingredients for the Johnson & Johnson and AstraZeneca vaccines a few weeks ago.
True, Johnson & Johnson immediately announced that such a slip-up will not prevent the company from meeting its commitment to deliver $ 100 million to the US in the first half of this year. vaccine dose.
Also, this goal can be achieved by the end of May. More than $ 1 billion is expected to be produced throughout the year. dose.
More than $ 150 million was used in the United States on Wednesday. dose of coronavirus vaccine. 21 percent The US population 18 years and older has already been vaccinated with both doses and has acquired resistance to COVID-19.
[ad_2]
